TY - JOUR
T1 - The Portuguese severe asthma registry
T2 - development, features, and data sharing policies
AU - Rede de Especialistas em Asma Grave
AU - Sá-Sousa, Ana
AU - Fonseca, João Almeida
AU - Pereira, Ana Margarida
AU - Ferreira, Ana
AU - Arrobas, Ana
AU - Mendes, Ana
AU - Drummond, Marta
AU - Videira, Wanda
AU - Costa, Tiago
AU - Farinha, Pedro
AU - Soares, José
AU - Rocha, Pedro
AU - Todo-Bom, Ana
AU - Sokolova, Anna
AU - Costa, António
AU - Fernandes, Beatriz
AU - Chaves Loureiro, Carla
AU - Longo, Cecília
AU - Pardal, Cecília
AU - Costa, Célia
AU - Cruz, Cíntia
AU - Loureiro, Cláudia Chaves
AU - Lopes, Cristina
AU - Mesquita, Duarte
AU - Faria, Emília
AU - Magalhães, Eunice
AU - Menezes, Fernando
AU - Todo-Bom, Filipa
AU - Carvalho, Francisca
AU - Regateiro, Frederico S.
AU - Falcão, Helena
AU - Fernandes, Ivone
AU - Gaspar-Marques, João
AU - Viana, Jorge
AU - Ferreira, José
AU - Silva, José Manuel
AU - Simão, Laura
AU - Almeida, Leonor
AU - Fernandes, Lígia
AU - Ferreira, Lurdes
AU - Van Zeller, Mafalda
AU - Quaresma, Márcia
AU - Castanho, Margarida
AU - André, Natália
AU - Cortesão, Nuno
AU - Leiria-Pinto, Paula
AU - Pinto, Paula
AU - Rosa, Paula
AU - Carreiro-Martins, Pedro
AU - Gerardo, Rita
N1 - Funding Information:
The authors thank all members of the REAG (Rede de Especialistas em Asma Grave), namely, Ana Morete, Ana Sofia Barroso, António Reis, Aurora Carvalho, Carmen Botelho, Catarina Ferreira, Cláudia Pinto, Dolores Moniz, Elza Tomás, Emília Alvares, Eugénia Almeida, Filipe Inácio, Isabel Car-rapatoso, Isabel Pereira, Jorge Romariz, José Pedro Moreira da Silva, Leonor Cunha, Luísa Barata, Luísa Geraldes, Luísa Semedo, Madalena Emiliano, Manuel Barbosa, Margarida Raposo, Maria José Silvestre, Mariana Mendes, Marta Dias Sousa, Nuno Sousa, Orlando Santos, Paula Duarte, Rosário Ferreira, Sofia Furtado, and Vítor Teixeira. RAG was financed by an unrestricted grant from Novartis Farma-Produtos Farmacêuticos, S.A., which had no participation in any part of the development and implementation of the registry and has no access to the stored data for any purpose. The first author is financed by a PhD Grant (PD/BD/113665/2015) and financed by the European Social Fund and national funds of MCTES (Ministério da Ciência, Tecnologia e Ensino Superior)through FCT (Funda¸cão para a Ciência e Tecnologia, I.P) PhD Programme Ref. PD/0003/2013-Doctoral Programme in Clinical and Health Services Research (PDICSS). The publication of this article was supported by ERDF (European Regional Development Fund) through the operation POCI-01-0145-FEDER-007746 funded by the Programa Operacional Com-petitividade e Internacionalizac¸ão – COMPETE2020 and by National Funds through FCT - Fundac¸ão para a Ciência e a Tecnologia within CINTESIS, R&D Unit (reference UID/IC/4255/2013).
Funding Information:
The authors thank all members of the REAG (Rede de Especialistas em Asma Grave), namely, Ana Morete, Ana Sofia Barroso, António Reis, Aurora Carvalho, Carmen Botelho, Catarina Ferreira, Cláudia Pinto, DoloresMoniz, Elza Tomás, Emília Alvares, Eugénia Almeida, Filipe Inácio, Isabel Carrapatoso, Isabel Pereira, Jorge Romariz, José Pedro Moreira da Silva, Leonor Cunha, Luísa Barata, Luísa Geraldes, Luísa Semedo, Madalena Emiliano, Manuel Barbosa, Margarida Raposo, Maria José Silvestre, Mariana Mendes, Marta Dias Sousa, Nuno Sousa, Orlando Santos, Paula Duarte, Rosário Ferreira, Sofia Furtado, and Vítor Teixeira. RAG was financed by an unrestricted grant from Novartis Farma-Produtos Farmacêuticos, S.A.,which had no participation in any part of the development and implementation of the registry and has no access to the stored data for any purpose. The first author is financed by a PhD Grant (PD/BD/113665/2015) and financed by the European Social Fund and national funds of MCTES (Ministério da Ciência, Tecnologia e Ensino Superior) through FCT (Fundação para a Ciência e Tecnologia, I.P) PhD Programme Ref. PD/0003/2013-Doctoral Programme in Clinical and Health Services Research (PDICSS). The publication of this article was supported by ERDF (European Regional Development Fund) through the operation POCI-01-0145- FEDER-007746 funded by the Programa Operacional Competitividade e Internacionalização - COMPETE2020 and by National Funds through FCT - Fundação para a Ciência e a Tecnologia within CINTESIS, R&D Unit (reference UID/IC/4255/2013).
Publisher Copyright:
© 2018 Ana Sá-Sousa et al.
PY - 2018
Y1 - 2018
N2 - The Portuguese Severe Asthma Registry (Registo de Asma Grave Portugal, RAG) was developed by an open collaborative network of asthma specialists. RAG collects data from adults and pediatric severe asthma patients that despite treatment optimization and adequate management of comorbidities require step 4/5 treatment according to GINA recommendations. In this paper, we describe the development and implementation of RAG, its features, and data sharing policies. The contents and structure of RAG were defined in a multistep consensus process. A pilot version was pretested and iteratively improved. The selection of data elements for RAG considered other severe asthma registries, aiming at characterizing the patient's clinical status whilst avoiding overloading the standard workflow of the clinical appointment. Features of RAG include automatic assessment of eligibility, easy data input, and exportable data in natural language that can be pasted directly in patients' electronic health record and security features to enable data sharing (among researchers and with other international databases) without compromising patients' confidentiality. RAG is a national web-based disease registry of severe asthma patients, available at asmagrave.pt. It allows prospective clinical data collection, promotes standardized care and collaborative clinical research, and may contribute to inform evidence-based healthcare policies for severe asthma.
AB - The Portuguese Severe Asthma Registry (Registo de Asma Grave Portugal, RAG) was developed by an open collaborative network of asthma specialists. RAG collects data from adults and pediatric severe asthma patients that despite treatment optimization and adequate management of comorbidities require step 4/5 treatment according to GINA recommendations. In this paper, we describe the development and implementation of RAG, its features, and data sharing policies. The contents and structure of RAG were defined in a multistep consensus process. A pilot version was pretested and iteratively improved. The selection of data elements for RAG considered other severe asthma registries, aiming at characterizing the patient's clinical status whilst avoiding overloading the standard workflow of the clinical appointment. Features of RAG include automatic assessment of eligibility, easy data input, and exportable data in natural language that can be pasted directly in patients' electronic health record and security features to enable data sharing (among researchers and with other international databases) without compromising patients' confidentiality. RAG is a national web-based disease registry of severe asthma patients, available at asmagrave.pt. It allows prospective clinical data collection, promotes standardized care and collaborative clinical research, and may contribute to inform evidence-based healthcare policies for severe asthma.
UR - http://www.scopus.com/inward/record.url?scp=85058335902&partnerID=8YFLogxK
U2 - 10.1155/2018/1495039
DO - 10.1155/2018/1495039
M3 - Article
C2 - 30584531
AN - SCOPUS:85058335902
SN - 2314-6133
VL - 2018
JO - BioMed Research International
JF - BioMed Research International
M1 - 1495039
ER -